Intervention Protocol

You have free access to this content

Proton pump inhibitor-based triple therapies versus dual therapies for Helicobacter pylori eradication

  1. Sheikh Uzair1,*,
  2. Paul A Sutton1,
  3. Annie Herbert2,
  4. Khawar Hashmi3,
  5. Xavier Calvet4

Editorial Group: Cochrane Upper GI and Pancreatic Diseases Group

Published Online: 29 NOV 2013

DOI: 10.1002/14651858.CD010819


How to Cite

Uzair S, Sutton PA, Herbert A, Hashmi K, Calvet X. Proton pump inhibitor-based triple therapies versus dual therapies for Helicobacter pylori eradication (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 11. Art. No.: CD010819. DOI: 10.1002/14651858.CD010819.

Author Information

  1. 1

    Royal Bolton Hospital, Department of Surgery, Bolton, Lancashire, UK

  2. 2

    Pennine Acute Hospitals NHS Foundation Trust, Research and Development, Manchester, UK

  3. 3

    Royal Bolton Hospital, Bolton, UK

  4. 4

    Hospital de Sabadell & Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Servei de Malalties Digestives, Sabadell, Spain

*Sheikh Uzair, Department of Surgery, Royal Bolton Hospital, Minerva Road, Bolton, Lancashire, BL4 0JR, UK. sheikh.uzair@boltonft.nhs.uk. sheikh.uzair@rbh.nhs.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 29 NOV 2013

SEARCH

References

Additional references

Chey 2007
  • Chey WD, Wong BC, Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. American Journal of Gastroenterology 2007;102(8):1808-25.
    Direct Link:
de Martel 2006
Fock 2008
Higgins 2008
  • Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Chichester: John Wiley & Sons, 2008.
Kashifard 1998
  • Kashifard M, Malekzadeh R, Siavoshi F, Mikaeli J, Massarrat S. Continuous and more effective duodenal ulcer healing under therapy with bismuth and two antibiotics than with dual therapy comprising omeprazole and amoxicillin. European Journal of Gastroenterology and Hepatology 1998;10(10):847-50.
Labenz 1995
  • Labenz J, Stolte M, Peitz U, Tillenburg B, Köhl H, Becker T, et al. Omeprazole/amoxicillin versus triple therapy for Helicobacter pylori in duodenal ulcer disease: two-year follow-up of a prospective randomised study. Zeitschrift fur Gerontologie 1995;33(10):590-3.
Luzza 2001
  • Luzza F, Giglio A, Ciliberto E, Belmonte A, Cavaliere C, Saccà N, et al. Lansoprazole-based triple therapy versus ranitidine bismuth citrate-based dual therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer: a multicenter, randomised, double-dummy study. Clinical Therapeutics 2001;23(5):761-70.
Malfertheiner 2007
  • Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007;56(6):772-81.
Moayyedi 2009
  • Moayyedi P, Soo S, Deeks JJ, Delaney B, Harris A, Innes M, et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD002096.pub4]
Ohlin 2002
  • Ohlin B, Cederberg A, Kjellin T, Kullman E, Melén K, von Holstein CS, et al. Dual versus triple therapy in eradication of Helicobacter pylori. Hepato-Gastroenterology 2002;49(43):172-5.
RevMan 2012 [Computer program]
  • The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
Shirai 2007
  • Shirai N, Sugimoto M, Kodaira C, Nishino M, Ikuma M, Kajimura M, et al. Dual therapy with high doses of rabeprazole and amoxicillin versus triple therapy with rabeprazole, amoxicillin, and metronidazole as a rescue regimen for Helicobacter pylori infection after the standard triple therapy. European Journal of Clinical Pharmacology 2007;63(8):743-9.
Sung 1996
  • Sung JJ, Chung SC, Ling TK, Suen R, Leung VK, Lau JY, et al. Dual therapy versus triple therapy for Helicobacter pylori-associated duodenal ulcers. Digestive Diseases and Sciences 1996;41(3):453-7.
Tennvall 1999
  • Tennvall GR, Norinder A, Ohlin B. Cost effectiveness of Helicobacter pylori eradication therapies in patients with duodenal ulcer: an analysis of triple therapy versus two dual therapy alternatives. Pharmacoeconomics 1999;16(3):297-306.